SCHEMBL5115825

SCHEMBL5115825

CCOC(=O)c1cnc(-c2ccc(C)c(F)c2)nc1Cl

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.57
KDM4E B2RXH2 2/20 0.57
SMN1; SMN2 Q16637 5/20 0.49
NPC1 O15118 4/20 0.49
RAB9A P51151 4/20 0.49
LMNA P02545 3/20 0.49
MAPT P10636 2/20 0.49
HSD17B10 Q99714 1/20 0.49
MAPK1 P28482 1/20 0.49
ATM Q13315 1/20 0.49
TP53 P04637 1/20 0.48
CYP1A2 P05177 4/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
POLB P06746 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
CSNK1D P48730 2/20 0.45
FOS P01100 4/20 0.45
JUN P05412 4/20 0.45
NFKB1 P19838 4/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4181262 0.92 ALDH1A1 (0.58) ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A
SCHEMBL5111120 0.89 ALDH1A1 (0.60) ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A
SCHEMBL5124459 0.87 ALDH1A1 (0.50) ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A
SCHEMBL5119467 0.87 ALDH1A1 (0.57) ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A
SCHEMBL5120286 0.87 ALDH1A1 (0.53) ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A
SCHEMBL22573712 0.86 CSNK1D (0.60) ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A
SCHEMBL5125886 0.86 ALDH1A1 (0.59) ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A
SCHEMBL5126198 0.85 ALDH1A1 (0.54) ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A
SCHEMBL5278083 0.84 ALDH1A1 (0.39) ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A
SCHEMBL4951430 0.83 CYP1A2 (0.64) ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080194598-A1 Pyrimidine Carboxylic Acid Derivatives and Use Thereof BAYER HEALTHCARE AG (DE) 2008-08-14 US disclosed
US-20080194598-A1 Pyrimidine Carboxylic Acid Derivatives and Use Thereof BAYER HEALTHCARE AG (DE) 2008-08-14 US disclosed
US-20080194598-A1 Pyrimidine Carboxylic Acid Derivatives and Use Thereof BAYER HEALTHCARE AG (DE) 2008-08-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194598-A1 Pyrimidine Carboxylic Acid Derivatives and Use Thereof DPYD, TYMP, TYMS ALDH1A1 489/4885KDM4E 3188/4885SMN1; SMN2 4094/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.